Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yan Hao, Yulin Yang, Yongchao Wang & Jian Li. (2022) Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome. Current Medical Research and Opinion 38:10, pages 1663-1672.
Read now
Read now
Elnaz Karimian Azari, Aileen Kerrigan & Annalouise O’Connor. (2020) Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health. Journal of Dietary Supplements 17:5, pages 625-650.
Read now
Read now
Richard Kones & Umme Rumana. (2018) Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applications. Postgraduate Medicine 130:2, pages 200-221.
Read now
Read now
Bogusław Okopień, Lukasz Buldak & Aleksandra Bołdys. (2017) Fibrates in the management of atherogenic dyslipidemia. Expert Review of Cardiovascular Therapy 15:12, pages 913-921.
Read now
Read now
Peter P Toth. (2016) Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vascular Health and Risk Management 12, pages 171-183.
Read now
Read now
Valentina Perrone, Diego Sangiorgi, Stefano Buda & Luca Degli Esposti. (2016) Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study. ClinicoEconomics and Outcomes Research 8, pages 649-655.
Read now
Read now
Dinushan Nesan & Dominic S. Ng. (2014) Revising the high-density lipoprotein targeting strategies – Insights from human and preclinical studies. Critical Reviews in Clinical Laboratory Sciences 51:6, pages 321-331.
Read now
Read now
Richard Kones, Umme Rumana & Jordi Merino. (2014) Exclusion of ‘nonRCT evidence’ in guidelines for chronic diseases – is it always appropriate? The Look AHEAD study. Current Medical Research and Opinion 30:10, pages 2009-2019.
Read now
Read now
Articles from other publishers (49)
Zeltzin Alejandra Ceja-Galicia, Ana Karina Aranda-Rivera, Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Edilia Tapia, Joyce Trujillo, Victoria Ramírez & José Pedraza-Chaverri. (2023) The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids. Foods 12:5, pages 921.
Crossref
Crossref
Michael E. Makover, Michael D. Shapiro & Peter P. Toth. (2022) There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness. American Journal of Preventive Cardiology 12, pages 100371.
Crossref
Crossref
Tadeusz Osadnik, Marcin Goławski, Piotr Lewandowski, Jakub Morze, Kamila Osadnik, Natalia Pawlas, Mateusz Lejawa, Grzegorz K. Jakubiak, Agnieszka Mazur, Lucas Schwingschackl, Mariusz Gąsior & Maciej Banach. (2022) A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacological Research 183, pages 106402.
Crossref
Crossref
Gregory P Arutyunov, Alexander G Arutyunov, Fail T Ageev & Tatiana V Fofanova. (2022) Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or Hypertriglyceridemic Patients in the DIAPAsOn Study: Prospective Observational Study. JMIR Cardio 6:2, pages e37490.
Crossref
Crossref
Yongzheng Lu, Xiaolin Cui, Li Zhang, Xu Wang, Yanyan Xu, Zhen Qin, Gangqiong Liu, Qiguang Wang, Kang Tian, Khoon S Lim, Chris J Charles, Jinying Zhang & Junnan Tang. (2022) The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging and disease 13:2, pages 491.
Crossref
Crossref
Rui Huang, Li Yan & Yuhua Lei. (2021) The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Ruobing Ning, Xiaobo Deng, Qian Wang & Yaolei Ge. (2022) Carnosic Acid Protects Against Myocardial Infarction by Controlling Oxidative Stress and Inflammation in Rats. Revista Brasileira de Farmacognosia 31:6, pages 794-804.
Crossref
Crossref
Christina Kanonidou. (2021) Small dense low-density lipoprotein: Analytical review. Clinica Chimica Acta 520, pages 172-178.
Crossref
Crossref
Anna Bengtsson, Margareta Norberg, Nawi Ng, Bo Carlberg, Christer Grönlund, Johan Hultdin, Bernt Lindahl, Bertil Lindahl, Steven Nordin, Emma Nyman, Patrik Wennberg, Per Wester & Ulf Näslund. (2021) The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial. American Journal of Preventive Cardiology 7, pages 100199.
Crossref
Crossref
Gregory P Arutyunov, Alexander G Arutyunov, Fail T Ageev & Tatiana V Fofanova. (2021) Digital Technology Tools to Examine Patient Adherence to a Prescription-Only Omega-3 Polyunsaturated Fatty Acid Therapy To Mitigate Cardiovascular Risk: Protocol for a Prospective Observational Study and Preliminary Demographic Analysis. JMIR Research Protocols 10:8, pages e29061.
Crossref
Crossref
Muke Zhou, Jian Guo, Ning Chen, Mengmeng Ma, Shuju Dong, Yanbo Li, Jinghuan Fang, Yang Zhang, Yanan Zhang, Jiajia Bao, Ye Hong, You Lu, Mingfang Qin, Ling Yin, Xiaodong Yang, Quan He, Xianbin Ding, Liyan Chen, Zhuoqun Wang, Shengquan Mi, Shengyun Chen, Cairong Zhu, Dong Zhou & Li He. (2021) Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP): a protocol for a pragmatic, multicentre, observer-blinded, 12-month randomised controlled study. BMJ Open 11:3, pages e043450.
Crossref
Crossref
William E Boden, Seth Baum, Peter P Toth, Sergio Fazio & Deepak L Bhatt. (2021) Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction. Future Cardiology 17:1, pages 155-174.
Crossref
Crossref
Yu. A. Kotova, A. A. Zuykova, A. N. Pashkov, N. V. Strakhova & O. N. Krasnorutskaya. (2020) Indicators of oxidative stress, inflammation, and endothelial dysfunction in patients with coronary atherosclerosis while taking statins. Medical alphabet:2, pages 29-31.
Crossref
Crossref
Eunice Mah, C-Y Oliver Chen & DeAnn J Liska. (2019) The effect of egg consumption on cardiometabolic health outcomes: an umbrella review. Public Health Nutrition 23:5, pages 935-955.
Crossref
Crossref
E. K. Popova, N. S. Arkhipova & I. O. Popov. (2020) RISK PREDICTORS OF CORONARY HEART DISEASE IN MEN OF OLDER AGE GROUPS LIVING IN THE CONDITIONS OF FAR NORTH. Ekologiya cheloveka (Human Ecology) 27:2, pages 4-11.
Crossref
Crossref
Anika Niambi Al-Shura. 2020. Advanced Hematology in Integrated Cardiovascular Chinese Medicine. Advanced Hematology in Integrated Cardiovascular Chinese Medicine
93
96
.
Sarah Rückl, Tiago Couto, Juliana Parada & Carlos Eduardo Rosa. 2020. Women's Mental Health. Women's Mental Health
241
264
.
Umme Rumana, Richard Kones, Montather O. Taheer, Mohamed Elsayed & Craig W. Johnson. (2019) Trends in Guideline-Driven Revascularization in Diabetic Patients with Multivessel Coronary Heart Disease. Journal of Cardiovascular Development and Disease 6:4, pages 41.
Crossref
Crossref
Richard Kones, Alberto Morales-Salinas & Umme Rumana. (2019) Cardiac rehabilitation underutilization: Missed opportunities in comprehensive cardiac care. International Journal of Cardiology 292, pages 39-40.
Crossref
Crossref
Jianyong Zhong, Haichun Yang & Valentina Kon. (2018) Kidney as modulator and target of “good/bad” HDL. Pediatric Nephrology 34:10, pages 1683-1695.
Crossref
Crossref
Heitor O. Santos, Richard Kones, Umme Rumana, Conrad P. Earnest, Luiz F.M. Izidoro & Rodrigo C.O. Macedo. (2019) Lipoprotein(a): Current Evidence for a Physiologic Role and the Effects of Nutraceutical Strategies. Clinical Therapeutics 41:9, pages 1780-1797.
Crossref
Crossref
E. N. Lebedeva, A. A. Vyalkova, S. N. Afonina & S. A. Chesnokova. (2019) Dyslipidemia as a pathogenetic factor of the progression of the chronic kidney disease. Nephrology (Saint-Petersburg) 23:5, pages 56-64.
Crossref
Crossref
V. V. Belov & A. A. Menshchikov. (2019) Evaluation of the optimal values of cholesterol of high density lipoproteins in a cohort of men aged 40-59 with myocardial infarction (according to 30-year monitoring of the status of life). Cardiovascular Therapy and Prevention 18:1, pages 82-89.
Crossref
Crossref
Ulf Näslund, Nawi Ng, Anna Lundgren, Eva Fhärm, Christer Grönlund, Helene Johansson, Bernt Lindahl, Bertil Lindahl, Kristina Lindvall, Stefan K Nilsson, Maria Nordin, Steven Nordin, Emma Nyman, Joacim Rocklöv, Davide Vanoli, Lars Weinehall, Patrik Wennberg, Per Wester & Margareta Norberg. (2019) Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. The Lancet 393:10167, pages 133-142.
Crossref
Crossref
Zhao-Feng Chen, Lufei Young, Chong Yu & S. Shiao. (2018) A Meta-Prediction of Methylenetetrahydrofolate-Reductase Polymorphisms and Air Pollution Increased the Risk of Ischemic Heart Diseases Worldwide. International Journal of Environmental Research and Public Health 15:7, pages 1453.
Crossref
Crossref
Lutz E. Kraushaar & Alexander Dressel. (2018) The cardiovascular robustness hypothesis: Unmasking young adults' hidden risk for premature cardiovascular death. Medical Hypotheses 112, pages 51-59.
Crossref
Crossref
Zhongwei Huang, Haiyan Jiang, Xiaohui Cui, Guiwen Liang, Yu Chen, Ting Wang, Zhichao Sun & Lei Qi. (2017) Elevated serum levels of lipoprotein‑associated phospholipase�A2 predict mortality rates in patients with sepsis. Molecular Medicine Reports.
Crossref
Crossref
Scott Howell & Richard Kones. (2017) A Calorie is Still a Calorie, According to Rigorous New Evidence. Journal of Diabetes and Obesity 4:3, pages 1-2.
Crossref
Crossref
José Ramón González-Juanatey, José María Mostaza, José María Lobos, Benjamín Abarca, José Luis Llisterri, Gonzalo Baron-Esquivias, Enrique Galve, Rosa María Lidón, Francisco Xavier Garcia-Moll, Pedro Luis Sánchez, Carmen Suárez, Jesús Millán, Vicente Pallares, José Juan Alemán & Isabel Egocheaga. (2017) Documento de consenso del uso clínico de la Polypill en la prevención secundaria del riesgo cardiovascular. Medicina Clínica 148:3, pages 139.e1-139.e15.
Crossref
Crossref
José Ramón González-Juanatey, José María Mostaza, José María Lobos, Benjamín Abarca, José Luis Llisterri, Gonzalo Baron-Esquivias, Enrique Galve, Rosa María Lidón, Francisco Xavier Garcia-Moll, Pedro Luis Sánchez, Carmen Suárez, Jesús Millán, Vicente Pallares, José Juan Alemán & Isabel Egocheaga. (2017) Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease. Medicina Clínica (English Edition) 148:3, pages 139.e1-139.e15.
Crossref
Crossref
Anna Gluba-Brzózka, Beata Franczyk, Maciej Banach & Magdalena Rysz-Górzyńska. (2016) Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?. International Urology and Nephrology 49:1, pages 155-164.
Crossref
Crossref
Andy L. Olivares, Miguel A. González Ballester & Jérôme Noailly. (2016) Virtual exploration of early stage atherosclerosis. Bioinformatics 32:24, pages 3798-3806.
Crossref
Crossref
Xin-Hua Nabi, Chun-Yan Ma, Tabusi Manaer, Mulalibieke Heizati, Baheti Wulazibieke & Latipa Aierken. (2016) Anti-atherosclerotic effect of traditional fermented cheese whey in atherosclerotic rabbits and identification of probiotics. BMC Complementary and Alternative Medicine 16:1.
Crossref
Crossref
Samudrala Purnima & Bahiga Galal Abd El-Aal. (2016) Serum uric acid as prognostic marker of coronary heart disease (CHD). Clínica e Investigación en Arteriosclerosis 28:5, pages 216-224.
Crossref
Crossref
Amirhossein Sahebkar, Anna Hernández-Aguilera, David Abelló, Elena Sancho, Jordi Camps & Jorge Joven. (2016) Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism 65:5, pages 609-622.
Crossref
Crossref
Harry C. Blair, Jorge Sepulveda & Dionysios J. Papachristou. (2016) Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates. Vascular Pharmacology 78, pages 17-23.
Crossref
Crossref
V. A. Metelskaya, S. A. Shalnova, A. D. Deev, N. V. Perova, N. V. Gomyranova, O. A. Litinskaya, S. E. Evstifeeva, G. V. Artamonova, T. M. Gatagonova, Y. I. Grinshtein, D. V. Duplуakov, A. Y. Efanov, Y. V. Zhernakova, V. A. Ilyin, R. A. Libis, A. V. Minakov, V. A. Nevzorova, S. V. Nedogoda, S. A. Romanchuk, O. P. Rotar, I. A. Trubacheva, E. V. Shlyakhto & S. A. Boytsov. (2016) Analysis of atherogenic dyslipidemias prevalence among population of Russian Federation (results of the ESSE-RF Study). Profilakticheskaya meditsina 19:1, pages 15.
Crossref
Crossref
Richard Kones & Umme Rumana. (2016) Stable Ischemic Heart Disease. Heart Failure Clinics 12:1, pages 11-29.
Crossref
Crossref
Naga Venkata Pothineni, Sotirios K. Karathanasis & Jawahar L. Mehta. 2016. Translational Research in Coronary Artery Disease. Translational Research in Coronary Artery Disease
23
32
.
Yuqing He, Jie Yang, Danli Kong, Juanjuan Lin, Chengkai Xu, Han Ren, Ping Ouyang, Yuanlin Ding & Kai Wang. (2015) Association of miR-146a rs2910164 polymorphism with cardio-cerebrovascular diseases: A systematic review and meta-analysis. Gene 565:2, pages 171-179.
Crossref
Crossref
Valentina Kon, Haichun Yang & Sergio Fazio. (2015) Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein. Archives of Medical Research 46:5, pages 379-391.
Crossref
Crossref
Richard Kones & Umme Rumana. (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 75:11, pages 1201-1228.
Crossref
Crossref
V. V. Belov & A. A. Menshchikov. (2015) EVALUATION OF OPTIMAL HIGH DENSITY CHOLESTEROL VALUE IN COHORT OF ALMOST HEALTHY MEN 40-59 YEARS OLD (BY THE DATA OF 30-YEAR PROSPECTIVE OBSERVATION). Cardiovascular Therapy and Prevention 14:3, pages 60-64.
Crossref
Crossref
Deepesh Pandey, Daijiro Hori, Jae Hyung Kim, Yehudit Bergman, Dan E. Berkowitz & Lewis H. Romer. (2015) NEDDylation promotes endothelial dysfunction: A role for HDAC2. Journal of Molecular and Cellular Cardiology 81, pages 18-22.
Crossref
Crossref
Aleš Žák. (2015) Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?. Medical Science Monitor 21, pages 2156-2162.
Crossref
Crossref
Melvin George, Sandhiya Selvarajan, Rajaram Muthukumar & Shanmugam Elangovan. (2014) Looking into the Crystal Ball—Upcoming Drugs for Dyslipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 20:1, pages 11-20.
Crossref
Crossref
Jyoti Ankam, David I. Feldman, Michael J. Blaha & Seth S. Martin. (2014) Improving lipid control following myocardial infarction. Current Opinion in Cardiology 29:5, pages 454-466.
Crossref
Crossref
Richard Kones & Umme Rumana. (2014) Stable Ischemic Heart Disease. Cardiology Clinics 32:3, pages 333-351.
Crossref
Crossref
Hsin-Yuan Cheng, Runpei Wu & Catherine C. Hedrick. (2014) Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis 234:2, pages 265-269.
Crossref
Crossref